13F-HR filed by SILVERARC CAPITAL MANAGEMENT, LLC
SILVERARC CAPITAL MANAGEMENT, LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-12 16:14:50 UTC, with 70 holding rows worth $854,443,588.
- Accession
- 0001420506-26-002577
- Filer
- CIK 1816307
- Filed
- 2026-11-12
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 70 entries on the cover page, a total value of $854,443,588 stated on the cover page (in dollars after the unit check, H1), rows summing to $854,443,588 with VALUE read as dollars as filed, 13F file number 028-21010. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerSilverArc Capital, LLC 028-20993
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| KODIAK SCIENCES INC | 50015M109 | COM | 750,170 | $71,116,116 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 803,193 | $63,869,907 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 1,574,698 | $50,421,830 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 1,148,689 | $46,671,234 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 2,092,715 | $45,014,300 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 3,112,773 | $37,135,382 | dollars as filed | |
| SAGIMET BIOSCIENCES INC A | 786700104 | COMMON STOCK | 3,745,990 | $37,010,381 | dollars as filed | |
| ASCENDIS PHARMA A/S | K08588103 | ORD SHS *A* | 152,175 | $34,670,030 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 348,317 | $33,165,003 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 112,790 | $25,477,005 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 624,055 | $21,080,578 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 236,582 | $20,831,045 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 247,918 | $20,649,090 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 1,330,455 | $19,504,470 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 175,699 | $17,397,715 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 487,589 | $15,802,759 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 5,950,000 | $14,815,500 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 151,151 | $13,456,974 | dollars as filed | |
| DEFINIUM THERAPEUTICS INC | 24477V105 | COM SHS | 345,946 | $13,166,705 | dollars as filed | |
| HELIX ACQUISITION CORP III | G4444S107 | USD CL A ORD SHS | 1,208,030 | $12,829,279 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 300,427 | $12,173,302 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B902 | COM NEW | 370,700 | $12,014,387 | dollars as filed | call |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 3,454,647 | $11,503,975 | dollars as filed | |
| AVALYN PHARMA INC | 05348Y105 | COMMON STOCK | 378,352 | $10,779,248 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P909 | CALL | 702,400 | $9,461,328 | dollars as filed | call |
| CERUS CORP | 157085101 | COM | 3,950,595 | $9,402,416 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 6,565,960 | $9,126,684 | dollars as filed | |
| ZENAS BIOPHARMA INC COM | 98937L105 | Stock | 334,057 | $9,009,517 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 717,356 | $8,923,909 | dollars as filed | |
| RAINIER ACQUISITION CORP | G73591110 | UNIT | 853,875 | $8,709,525 | dollars as filed | |
| COMPUGEN LTD | M25722105 | ORD | 3,586,785 | $8,536,548 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 1,518,833 | $7,837,178 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 125,080 | $7,117,052 | dollars as filed | |
| Yarrow Bioscience, Inc. | 92941V407 | Common Stock, $0.0001 par value | 301,919 | $6,799,216 | dollars as filed | |
| IBIO INC | 451033708 | CMN | 5,357,088 | $6,321,364 | dollars as filed | |
| ARCTURUS THERAPEUTICS HLDGS | 03969T109 | COM | 459,899 | $6,296,017 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M902 | COM | 525,000 | $6,263,250 | dollars as filed | call |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 19,753 | $5,752,666 | dollars as filed | |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 75,697 | $5,647,753 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 121,452 | $5,567,360 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 760,337 | $5,497,237 | dollars as filed | |
| EVOMMUNE INC | 30054Y107 | COMMON STOCK | 594,027 | $4,906,663 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 247,418 | $4,651,458 | dollars as filed | |
| BENITEC BIOPHARMA INC | 08205P209 | COMMON STOCK | 443,109 | $4,431,090 | dollars as filed | |
| Research Alliance Corp Iii Ord Shs Cl A | G75226103 | Common Stock | 404,728 | $4,383,204 | dollars as filed | |
| BLOSSOMHILL THERAPEUTICS INC | 095130100 | COM | 202,104 | $3,767,219 | dollars as filed | |
| FAETH THERAPEUTICS INC | 81728A207 | COM NEW | 124,098 | $3,690,675 | dollars as filed | |
| ABEONA THERAPEUTICS INC | 00289Y206 | COM NEW | 693,441 | $3,640,565 | dollars as filed | |
| RESEARCH ALLIANCE CORP IV | G75228109 | CL A ORD SHS | 301,962 | $3,501,916 | dollars as filed | |
| Adlai Nortye | 00704R109 | SPONSORED ADS | 216,617 | $3,465,872 | dollars as filed | |
| PALISADE BIO INC | 696389402 | COMMON STOCK | 2,335,602 | $3,153,063 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 47,312 | $3,097,044 | dollars as filed | |
| ABSCI CORPORATION | 00091E959 | COM | 254,700 | $2,743,119 | dollars as filed | put |
| TELA BIO INC | 872381108 | COM | 2,137,201 | $2,457,781 | dollars as filed | |
| ZEVRA THERAPEUTICS INC COM NEW | 488445206 | Stock | 200,260 | $2,196,852 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 160,552 | $2,162,635 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 158,964 | $2,133,297 | dollars as filed | |
| MODERNA INC | 60770K107 | COM | 10,000 | $1,925,700 | dollars as filed | |
| ELUTIA INC | 05479K106 | CL A COM | 2,192,980 | $1,732,454 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616909 | COM | 391,900 | $1,450,030 | dollars as filed | call |
| UNIQURE NV | N90064101 | SHS | 56,704 | $1,369,969 | dollars as filed | |
| ACHIEVE LIFE SCIENCES INC | 004468500 | COMMON STOCK | 158,950 | $1,285,906 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 238,541 | $1,254,726 | dollars as filed | |
| RAPPORT THERAPEUTICS INC COM | 75383L102 | Stock | 35,524 | $1,193,606 | dollars as filed | |
| ZURA BIO LTD | G9TY5A901 | CALL | 242,200 | $1,007,552 | dollars as filed | call |
| CAMP4 THERAPEUTICS CORP | 13463J101 | COM | 183,063 | $739,575 | dollars as filed | |
| ANNEXON INC | 03589W902 | COM | 131,500 | $556,245 | dollars as filed | call |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 100,000 | $416,000 | dollars as filed | |
| CELLECTAR BIOSCIENCES INC | 15117F880 | COM NEW | 151,118 | $278,057 | dollars as filed | |
| Adagio Med Hldgs Inc Com | 00534B100 | Common Stock | 170,460 | $26,080 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-26-002577 | this filing | 2026-11-12 |